I think I recall a couple of years ago there was a study that was shown, respected, and you probably know it better than I, that $2 million for gene therapy for ultra-rare diseases was a reasonable sort of--it would cover the cost.
Cassidy discusses the cost of gene therapy for ultra-rare diseases.
Share
More from Bill Cassidy
At a time when hostile actors are increasingly using sophisticated tactics to breach health care systems, the Health Care Cybersecurity and Resilience Act will help health care providers strengthen their defenses against cyber threats and…
You’ll also need to ensure that uninformed ideologies do not influence FDA’s decisions on whether to approve individual products, even if the president is pressuring you.
Even though in your mind it might be a gift, the appearance of it is really bad.
Other voices in this conversation
